Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jun;12(6):817-822.
doi: 10.1002/mdc3.14354. Epub 2025 Feb 7.

Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study

Affiliations
Multicenter Study

Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study

Emma N M M von Scheibler et al. Mov Disord Clin Pract. 2025 Jun.

Abstract

Background: 22q11.2 deletion syndrome (22q11.2DS) has been associated with increased risk of early-onset Parkinson's disease (PD).

Objective: To determine the prevalence and predictors of PD in a large international 22q11.2DS sample.

Methods: The sample comprised 856 adults (median age 28 (range 16-76) years; 53.0% female). PD was defined as clinical diagnosis by a neurologist (including bradykinesia, rest tremor and/or rigidity). Age-specific risk and predictors of PD were analyzed using Kaplan-Meier curve and Cox regression.

Results: PD was present in 1.8% (95% CI: 0.9-2.6%) of the sample, 3.4% (95% CI: 2.2-4.6%) when including uncertain PD (clinical diagnosis or suspicion, but not meeting all criteria), and 14.0% (95% CI: 6.9-21.0%) of those aged ≥50 years. Median age at motor onset was 45 (range 20-66) years. None of the factors considered were associated with PD.

Conclusions: Given high PD prevalence and young onset, we propose periodic motor evaluations from age 40 years in 22q11.2DS.

Keywords: 22q11.2; Parkinson's disease; epidemiology; genetics; parkinsonism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier curve showing the probability of being diagnosed with Parkinson's disease (y‐axis) by a given age (x‐axis) among 856 adults with 22q11.2 deletion syndrome. Censored data (indicated by plus symbols) represent age (at last assessment or at death) for individuals who have not been diagnosed with PD. It should be noted that the number of adults aged 60 years or older was limited (n = 26). PD, Parkinson's disease.

References

    1. Blagojevic C, Heung T, Theriault M, et al. Estimate of the contemporary live‐birth prevalence of recurrent 22q11.2 deletions: a cross‐sectional analysis from population‐based newborn screening. CMAJ Open 2021;9(3):E802–E809. - PMC - PubMed
    1. Butcher NJ, Kiehl TR, Hazrati LN, Chow EWC, Rogaeva E, Lang AE, Bassett AS. Association between early‐onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol 2013;70(11):1359–1366. - PMC - PubMed
    1. Mok KY, Sheerin U, Simón‐Sánchez J, et al. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome‐wide association data. Lancet Neurol 2016;15(6):585–596. - PMC - PubMed
    1. Boot E, Butcher NJ, Udow S, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology 2018;90(23):e2059–e2067. - PMC - PubMed
    1. McDonald‐McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015;1:15071. - PMC - PubMed

Publication types

LinkOut - more resources